865 participants
Study of a Respiratory Syncytial Virus Candidate Encapsulated in a Lipid Nanoparticle Based Formulation in Adults Aged 18 to 50 Years and 60 Years and Older
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-08-05
- Start Date:
- 2022-11-17
- Completion:
- 2025-05-02
Conditions
- Respiratory Syncytial Virus Immunization
Interventions
- BIOLOGICAL
- OTHER